205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models

205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models

Bibliographic Details
Main Authors:	Burcu Yigit, Xavier Michelet, Darrian Moskowitz, Marc Van Dijk, Antoine Tanne
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing
by: Burcu Yigit, et al.
Published: (2020-11-01)

735 Peripheral and tissue persistence of agenT-797, an allogeneic iNKT cell-based cell therapy for the treatment of cancer
by: Rachel E Sanborn, et al.
Published: (2023-11-01)

135 Identification and characterization of an allogeneic iNKT-CAR targeting BCMA
by: Xavier Michelet, et al.
Published: (2021-11-01)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
by: Yan-Ruide Li, et al.
Published: (2021-11-01)

iNKT and MAIT cell alterations in diabetes
by: Isabelle eMagalhaes, et al.
Published: (2015-07-01)

The Role of Autophagy in iNKT Cell Development
by: Guan Yang, et al.
Published: (2018-11-01)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
by: Takahiro Aoki, et al.
Published: (2023-05-01)

The iNKT Cell–Macrophage Axis in Homeostasis and Disease
by: Mariana S. Cruz, et al.
Published: (2022-01-01)

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease.
by: Joshua J Field, et al.
Published: (2017-01-01)

Human iNKT Cells Modulate Macrophage Survival and Phenotype
by: J. Pedro Loureiro, et al.
Published: (2022-07-01)

Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
by: Diana Ferraro, et al.
Published: (2021-11-01)

CD8+ T-cell immunity orchestrated by iNKT cells
by: Yingyu Qin, et al.
Published: (2023-01-01)

New insights into iNKT cells and their roles in liver diseases
by: Xinyu Gu, et al.
Published: (2022-10-01)

Developmental dynamics of post-selection thymic DN iNKT.
by: Maryam Yassai, et al.
Published: (2012-01-01)

Histone deacetylase 3 is required for iNKT cell development
by: Puspa Thapa, et al.
Published: (2017-07-01)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
by: Kevin O. McNerney, et al.
Published: (2020-05-01)

The Ras/MAPK pathway is required for generation of iNKT cells.
by: Taishan Hu, et al.
Published: (2011-05-01)

The impact of stress on the transcriptomic signature of iNKT1 cells
by: Georgia Papadogianni, et al.
Published: (2021-12-01)

Single-cell analysis reveals differences among iNKT cells colonizing peripheral organs and identifies Klf2 as a key gene for iNKT emigration
by: Jie Wang, et al.
Published: (2022-08-01)

The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells.
by: Toshiaki Yasuoka, et al.
Published: (2016-01-01)

Characterization and Functional Analysis of Mouse Invariant Natural T (iNKT) Cells
by: Bezbradica, J, et al.
Published: (2006)

Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balance.
by: Cerundolo, V, et al.
Published: (2010)

The complement system and invariant natural killer T (iNKT) cell responses
by: Malik, N
Published: (2021)

Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment
by: Agnieszka Lawrenczyk, et al.
Published: (2014-07-01)

iNKT cell production of GM-CSF controls Mycobacterium tuberculosis.
by: Alissa C Rothchild, et al.
Published: (2014-01-01)

iNKT Cells and Their potential Lipid Ligands during Viral Infection
by: Anunya eOpasawatchai, et al.
Published: (2015-07-01)

The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in Tissues
by: Filippo Cortesi, et al.
Published: (2018-10-01)

iNKT: A new avenue for CAR-based cancer immunotherapy
by: Yilin Liu, et al.
Published: (2022-03-01)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.
by: Felix Scheuplein, et al.
Published: (2015-01-01)

Bystander activation of iNKT cells occurs during conventional T-cell alloresponses
by: Jukes, J, et al.
Published: (2012)

Bystander activation of iNKT cells occurs during conventional T-cell alloresponses.
by: Jukes, J, et al.
Published: (2012)

Perturbation of mucosal-associated invariant T cells and iNKT cells in HIV infection
by: Juno, J, et al.
Published: (2018)

Role of CD1d and iNKT cells in regulating intestinal inflammation
by: Sung Won Lee, et al.
Published: (2024-01-01)

License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity
by: Angélica Díaz-Basabe, et al.
Published: (2020-05-01)

22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
by: Travis Shute, et al.
Published: (2021-03-01)

Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
by: Rebeca Jimeno, et al.
Published: (2019-12-01)

Diacylglycerol kinase zeta positively controls the development of iNKT-17 cells.
by: Jinhong Wu, et al.
Published: (2013-01-01)

TCR signal strength controls thymic differentiation of iNKT cell subsets
by: Kathryn D. Tuttle, et al.
Published: (2018-07-01)

How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets
by: Haiguang Wang, et al.
Published: (2018-06-01)

Regulated expression of miR-155 is required for iNKT cell development
by: Alessia eBurocchi, et al.
Published: (2015-03-01)